Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
OWNR
Optipharm
★
Optipharm CEO Hyunil Kim Increases Stake to 2.09% via Small Open-Market Purchases... Routine Disclosure with Negligible Shareholder Impact
05/29/2026, 03:34 PM
EXCH
Optipharm
★
Holding of 2026 Q1 Earnings Conference Call (IR)
05/20/2026, 01:28 PM
PERI
Optipharm
★
Optipharm Q1 2026 Sales Up 9.0% but Operating Loss of KRW 723M Persists
05/15/2026, 03:51 PM